The neurointerventional device market in the united states is on a robust growth trajectory, with projections indicating a compound annual growth rate (CAGR) of 4.6% from 2023 to 2033. This growth is primarily driven by advancements in technology, increasing prevalence of neurovascular disorders, and rising demand for minimally invasive surgical procedures.
Neurointerventional devices, including stents, coils, and embolic agents, play a crucial role in treating conditions such as aneurysms, arteriovenous malformations, and acute ischemic stroke. The rise in patient awareness regarding treatment options and the growing preference for minimally invasive techniques are significantly contributing to market expansion.
The global neurointerventional devices market is on a significant upward trajectory, with its market size forecasted to grow from USD 2.6 billion in 2023 to approximately USD 4.1 billion by 2033, the market is further expected to surge at a CAGR of 4.7% during the forecast period 2023 to 2033, according to a recent industry study. This growth is fueled by rising global healthcare expenditures and the implementation of improved reimbursement policies for neurointerventional procedures.
Key factors influencing market growth include:
- Technological Innovations: The introduction of advanced neurointerventional devices with enhanced safety and efficacy is expected to boost market demand. Manufacturers are increasingly focusing on developing devices that improve patient outcomes and reduce procedural complications.
- Rising Incidence of Neurological Disorders: The increasing prevalence of stroke and other neurovascular diseases is fueling the demand for neurointerventional procedures. According to the American Heart Association, stroke is a leading cause of death and disability, emphasizing the need for effective treatment options.
- Growth in Healthcare Infrastructure: Enhanced healthcare facilities and improved access to specialized neurointerventional services are also contributing to the market’s growth. Investments in healthcare infrastructure are paving the way for advanced neurointerventional therapies.
- Government Initiatives: Government initiatives aimed at improving neurological health are expected to further stimulate market growth. Programs promoting research and development in neurointerventional devices are enhancing the overall healthcare landscape.
As the market evolves, key players are focusing on strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their product offerings. With an increasing emphasis on research and innovation, the neurointerventional device market in the U.S. is poised for significant growth in the coming years.
Key Market Insights:
- The global neurointerventional devices market is projected to reach USD 4.1 billion by 2033.
- The market is anticipated to grow at a CAGR of 4.7% from 2023 to 2033.
- By end-user, the hospitals segment is expected to expand at a CAGR of 4.5% through 2033.
- The Indian market is forecasted to grow at a CAGR of 4.5% through 2033.
“The digitalization of healthcare records and patient data can facilitate seamless communication between healthcare providers, potentially improving the utilization of neurointerventional devices,” remarks an FMI analyst.
High Demand for Neurointerventional Device: Uncover the Trends and Insights with Our Detailed Report!
Competitive Landscape:
Prominent players in the neurointerventional devices market include Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited, Terumo Corporation, Medtronic, Boston Scientific, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., Abbott, Philips Healthcare, and Siemens Healthineers.
As the market continues to evolve, key players are expected to focus on expanding their product portfolios and strengthening distribution networks to capitalize on emerging opportunities in this dynamic sector.
Recent Developments:
- Johnson & Johnson launched the EmboTrap™ II Embolic Capture Device in 2023, designed to enhance stroke treatment.
- Boston Scientific introduced the ACURUN™ Onyx™ Liquid Embolic System in 2022, targeting vascular malformations and neurovascular disorders.
Market Segmentation:
- By Product: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, and more.
- By Technique: Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures.
- By End User: Hospitals, Ambulatory Surgical Centers.
- By Region: North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, The Middle East & Africa.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
